Goelzer Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$645M Sell
537,488
-2,929
-0.5% -$2.99M 28.1% 1
2026
Q1
$497M Sell
540,417
-2,450
-0.5% -$2.48M 24.04% 1
2025
Q4
$583M Sell
542,867
-1,625
-0.3% -$1.55M 27.06% 1
2025
Q3
$415M Sell
544,492
-13,167
-2% -$9.8M 22.02% 1
2025
Q2
$435M Buy
557,659
+7,349
+1% +$5.71M 23.82% 1
2025
Q1
$455M Buy
550,310
+2,872
+0.5% +$2.39M 26.32% 1
2024
Q4
$423M Buy
547,438
+568
+0.1% +$470K 24.53% 1
2024
Q3
$484M Sell
546,870
-21,459
-4% -$19.3M 26.55% 1
2024
Q2
$515M Sell
568,329
-15,072
-3% -$12.1M 28.79% 1
2024
Q1
$454M Sell
583,401
-5,886
-1% -$4.19M 25.71% 1
2023
Q4
$344M Sell
589,287
-59,135
-9% -$34.5M 22.09% 1
2023
Q3
$348M Buy
648,422
+561,464
+646% +$289M 24.51% 1
2023
Q2
$40.8M Sell
86,958
-133
-0.2% -$55.8K 3.45% 6
2023
Q1
$29.9M Buy
87,091
+294
+0.3% +$99.2K 2.6% 6
2022
Q4
$31.8M Buy
86,797
+265
+0.3% +$94K 2.72% 6
2022
Q3
$28M Buy
86,532
+224
+0.3% +$71K 2.8% 5
2022
Q2
$28M Sell
86,308
-768
-0.9% -$231K 2.7% 5
2022
Q1
$24.9M Sell
87,076
-403
-0.5% -$104K 2.16% 7
2021
Q4
$24.2M Buy
87,479
+1,878
+2% +$476K 1.97% 10
2021
Q3
$19.8M Sell
85,601
-16,017
-16% -$3.95M 1.73% 9
2021
Q2
$23.3M Sell
101,618
-3,297
-3% -$662K 1.94% 9
2021
Q1
$19.6M Sell
104,915
-5,941
-5% -$1.16M 1.73% 10
2020
Q4
$18.7M Sell
110,856
-201,334
-64% -$30.1M 1.72% 10
2020
Q3
$46.2M Sell
312,190
-141
-0% -$21.8K 4.27% 1
2020
Q2
$51.3M Buy
312,331
+1,641
+0.5% +$252K 4.94% 1
2020
Q1
$43.1M Buy
310,690
+89
+0% +$12.2K 4.91% 1
2019
Q4
$40.8M Sell
310,601
-900
-0.3% -$104K 3.5% 1
2019
Q3
$34.8M Sell
311,501
-600
-0.2% -$66.8K 3.19% 2
2019
Q2
$34.6M Sell
312,101
-50
-0% -$5.89K 3.19% 2
2019
Q1
$40.5M Buy
312,151
+290,557
+1,346% +$35.3M 3.84% 1
2018
Q4
$2.5M Sell
21,594
-1,077
-5% -$120K 0.32% 106
2018
Q3
$2.43M Sell
22,671
-2,827
-11% -$283K 0.27% 119
2018
Q2
$2.18M Sell
25,498
-3,312
-11% -$272K 0.25% 130
2018
Q1
$2.23M Sell
28,810
-1,547
-5% -$125K 0.27% 127
2017
Q4
$2.56M Buy
30,357
+7,686
+34% +$654K 0.29% 120
2017
Q3
$1.94M Sell
22,671
-184
-0.8% -$15.1K 0.23% 130
2017
Q2
$1.88M Sell
22,855
-375
-2% -$30.6K 0.23% 130
2017
Q1
$1.95M Sell
23,230
-1,983
-8% -$159K 0.24% 129
2016
Q4
$1.85M Sell
25,213
-215
-0.8% -$16K 0.24% 134
2016
Q3
$2.04M Sell
25,428
-625
-2% -$50K 0.28% 130
2016
Q2
$2.05M Sell
26,053
-126
-0.5% -$9.49K 0.28% 128
2016
Q1
$1.89M Sell
26,179
-2,567
-9% -$194K 0.27% 131
2015
Q4
$2.42M Sell
28,746
-300
-1% -$24.9K 0.35% 118
2015
Q3
$2.43M Buy
29,046
+3,108
+12% +$262K 0.39% 115
2015
Q2
$2.17M Sell
25,938
-506
-2% -$38.6K 0.33% 124
2015
Q1
$1.92M Sell
26,444
-846
-3% -$60.2K 0.29% 129
2014
Q4
$1.88M Sell
27,290
-1,028
-4% -$69.4K 0.28% 129
2014
Q3
$1.84M Buy
28,318
+5,615
+25% +$356K 0.3% 121
2014
Q2
$1.41M Sell
22,703
-930
-4% -$55.5K 0.23% 128
2014
Q1
$1.39M Sell
23,633
-870
-4% -$48.6K 0.25% 128
2013
Q4
$1.25M Sell
24,503
-208
-0.8% -$10.4K 0.23% 132
2013
Q3
$1.24M Sell
24,711
-73,791
-75% -$3.86M 0.25% 126
2013
Q2
$4.84M Buy
+98,502
New +$5.36M 0.52% 96

Other funds holding LLY

Goelzer Investment Management's LLY Position: Q2 2026 in Review

Goelzer Investment Management reduced its Eli Lilly (LLY) stake by 0.54% in Q2 2026, selling an estimated $2.99M and leaving 537,488 shares worth $645M. The position accounts for 28.1% of the portfolio, ranked #1.

Goelzer Investment Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Goelzer Investment Management held 537,488 shares of Eli Lilly worth $645M as of Q2 2026.
  • Goelzer Investment Management sold 2,929 Eli Lilly shares in Q2 2026, an estimated $2.99M.
  • Eli Lilly made up 28.1% of Goelzer Investment Management's portfolio in Q2 2026, its #1 holding.
  • Goelzer Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Goelzer Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.